WHO ICTRP trial
Chlorhexidine and nystatin in the treatment of oral candidosis - a pilot study
EUCTR2016-005027-81-FI · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2016-005027-81-FI |
|---|---|
| Public title | Chlorhexidine and nystatin in the treatment of oral candidosis - a pilot study |
| Scientific title | Chlorhexidine and nystatin in the treatment of oral candidosis - a pilot study |
| Primary sponsor | Maria Siponen |
| Secondary sponsors | Maria Siponen |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): yes |
| Countries | Finland |
| Conditions | oral candidosis;Therapeutic area: Diseases [C] - Bacterial Infections and Mycoses [C01] |
| Interventions | Trade Name: Mykundex Product Name: Mykundex Pharmaceutical Form: Suspension for oral suspension INN or Proposed INN: NYSTATIN CAS Number: 400-61-9 Concentration unit: IU/ml international unit(s)/millilitre Concentration type: equal Trade… |
| Registration date | Aug 14, 2018 |
| Target size | 40 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: